Innovation Through Pioneering Technology SM


Call us today 212-583-0100

For billing information:

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Monday, December 13, 2004 ENZO Biochem Reports Fiscal 2005 First Quarter Operating Results and Sequential Gains
Wednesday, December 08, 2004 Discussion of Fiscal 2005 First Quarter Operating Results
Thursday, November 11, 2004 ENZO Life Sciences Launches New Advanced Amplification Technology for Gene Expression Analysis Studies
Monday, November 01, 2004 ENZO Biochem Presents Five Papers Covering Pre-Clinical Research Results At Liver Disease Conference
Thursday, October 14, 2004 ENZO Biochem Announces Settlement Agreement With Digene Corporation For Payments In Excess Of $30.5 Million
Thursday, October 14, 2004 ENZO Biochem Reports Operating Results
Thursday, October 07, 2004 ENZO Biochem Declares 5% Stock Dividend
Wednesday, September 29, 2004 ENZO Biochem Reports Phase II Data of Alequel™ for Management of Crohn’s Disease Trial Successfully
Friday, September 24, 2004 ENZO Biochem to Present At 2004 UBS Global Life Sciences Conference
Wednesday, July 28, 2004 ENZO Biochem Reports Court Ruling
Tuesday, July 20, 2004 ENZO Biochem Announces Supply And License Agreement With GlaxoSmithKline
Wednesday, July 14, 2004 ENZO Biochem Appoints Marcus A. Conant, M.D. To Its Board Of Directors
Monday, June 14, 2004 ENZO Biochem Granted European Patent For Displacer Technology To Treat Gene Abnormalities
Monday, June 14, 2004 ENZO Biochem Reports Results for Fiscal 2004 Third Quarter
Thursday, June 10, 2004 ENZO Biochem to Present at Needham & Company Third Annual Biotechnology Conference
Tuesday, June 08, 2004 ENZO Biochem, Inc. Files Patent Infringement Lawsuit Involving Dna Sequencing Against Applera Corp. and Subsidiary
Tuesday, June 08, 2004 ENZO Biochem’s Subsidiary Issued United States Patent Relating To Methods Of Nucleic Acid Amplification
Thursday, June 03, 2004 ENZO Rejects Roche Settlement Offer Roche Responds With Lawsuit
Thursday, May 20, 2004 ENZO Biochem to Begin Clinical Trial on New Immunomodulatory Agent
Monday, May 17, 2004 ENZO Biochem Presenting Preclinical Data On Compound For Treating Immune Mediated Disorders
Wednesday, April 21, 2004 ENZO Biochem, University of Connecticut Enter Exclusive Licensing Agreements for Development of Novel Therapeutics to Spur Bone Growth
Tuesday, March 23, 2004 ENZO Biochem Reports on Preclinical Study That Points To Development of New Compound For Treating Immune Mediated Diseases
Tuesday, March 16, 2004 ENZO Biochem Reports Operating Results For Fiscal 2004 Second Quarter
Thursday, March 11, 2004 ENZO Biochem Reports Interim Results for Clinical Trial of Alequel™, Its Investigational Treatment for Management of Crohn’s Disease
Thursday, February 26, 2004 ENZO Biochem Acquires Assets of Oragen Corporation, a Biotech Firm Involved In Immune Regulation
Wednesday, January 14, 2004 Phase I/II Hiv Gene Therapy Trial Initiated Enzo Biochem Tells Annual Meeting

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.